midterm pharm2

2 weeks old

child should receive missed doses

hbv vaccine (hep b) dtap ,ipv(polio)MMR VARICELLA AND HIB vaccines can be administered together at separate site injections

• HBV is a pediatric disease the infection occurs in childhood  and adolescence and can lead to fatal consequences from cirrhosis or liver cancer during adulthood
• it is received within 12 hours of birth 0.5 ml in vatus lateris
• can be given with dtap mmr hib
• avoid dorsal gluteal site because it is associated with low antibody seroconversion rates indicating a reduced immune response

respiratory nasopharyngitis or obstructive laryngotraceaitis with upper airway obstruction

• 1.combo with tetanus and percusis(dtap)and hib vaccines for children younger than 7 
• 2.in combo with conjugate H.influenza type B
• 3. combined with tetanus (DT) for children younger than 7 and who have contradictions receiving pertussis
• 4.in combo with tetanus and acellular pertussis TDAP for children 11 and older
• 5. single antigen when combined preparations are not indicated

boosters given every 10 years for life persist for 10 years or more when given at the correct age

• tetanus toxoid-used for primary injection
• tetanus immunoglobin(TIG)
• tetanus antitoxin-no longer given in the usa

• boostrix- licensed for people 10=65
• adacel for people 11=64

• all children 6 wks to 6 years of age
• children with no neurological contradictions

1. whole cell pertussis-is prepared from inactivated cells of bordetella pertusis ad contain multipleantigens

• 2. acellular pertussis and contains one or more immunogens derived from the b pertussis organism. is associated with fewer local and systemic reactions than those occurring w/whole cell
• first 3 immunizations are given at 2,4,6 months of age w/diptheriaand tetanus

nurses should receive a single dose of TDAP and droplet precautions against droplet contamination

because of rare risk of vaccine-associated polio paralysis from oral polio vaccine

• MMRV(MEASLES,MUMPS,RUBELLA,VARICELLA)
• should be fully explained risk is 5-12 days in children 
• 12-23 mths remains low and should be weighed with benifit

vitamin A supplementation

maternal antibodies can interfere with immune response

• protects unborn child 
• targeted group is all unimmunized prepubertal children and susceptible adolescents  and adult women in their childbearing years

• HPV4-for female children and adolescents 11-12 min age  to prevent hpv related cervical cancers
•           administered IM in 3 separate dosages 2nd dose admin 2 mths after the first 3rd dose given 6 mths after first dose 
• may be admin to boys 9-26 in 3 dose series to reduce likelihood of genital warts

hpv2-girls and women 10-25 for prevention of hpv realted to cervical cancers given in 3 dose series

varicella and MMR

• should not be given to immunocompromised pts 
• should be postponed 3 months after newly acquired immunity ex.. blood transfusion maternal antibodies 
• allergic response to previous vaccination
• pregnancy contradiction